Amy C Janes1, Jennifer Betts2, J Eric Jensen3, Scott E Lukas3. 1. McLean Imaging Center, McLean Hospital, 115 Mill Street, Belmont, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address: ajanes@mclean.harvard.edu. 2. McLean Imaging Center, McLean Hospital, 115 Mill Street, Belmont, MA, United States. 3. McLean Imaging Center, McLean Hospital, 115 Mill Street, Belmont, MA, United States; Harvard Medical School, Boston, MA, United States.
Abstract
BACKGROUND: When exposed to smoking cues, nicotine dependent individuals activate brain regions overlapping with the default mode network (DMN), a network of regions involved in internally-focused cognition. The salience network (SN), which includes the dorsal anterior cingulate cortex (dACC), is thought to interact with the DMN and aids in directing attention toward salient internal or external stimuli. One possibility is that neurochemical variation in SN regions such as the dACC impact DMN reactivity to personally relevant stimuli such as smoking cues. This is consistent with emerging evidence suggesting an association between midline cortical glutamate (Glu) and activity in brain regions overlapping with the DMN. METHODS: In 18 nicotine-dependent individuals, we assessed the relationship between DMN activation to smoking relative to neutral cues using functional magnetic resonance imaging and dACC Glu as measured by magnetic resonance spectroscopy. This association also was tested in a replication sample of 14 nicotine-dependent participants. RESULTS: Not only was the DMN significantly less suppressed during smoking cue exposure, but also there was a positive association between DMN reactivity to smoking relative to neutral cues and dACC Glu (r=0.56, p<0.02). This finding was confirmed in the independent replication cohort (r=0.64, p<0.02). CONCLUSIONS: The current findings confirm that the DMN is less suppressed when smokers view smoking relative to neutral cues, suggesting that smoking cues engage self-relevant processing. Furthermore, these results indicate that dACC Glu is associated with enhanced DMN engagement when nicotine-dependent individuals are exposed to self-relevant smoking cues.
BACKGROUND: When exposed to smoking cues, nicotine dependent individuals activate brain regions overlapping with the default mode network (DMN), a network of regions involved in internally-focused cognition. The salience network (SN), which includes the dorsal anterior cingulate cortex (dACC), is thought to interact with the DMN and aids in directing attention toward salient internal or external stimuli. One possibility is that neurochemical variation in SN regions such as the dACC impact DMN reactivity to personally relevant stimuli such as smoking cues. This is consistent with emerging evidence suggesting an association between midline cortical glutamate (Glu) and activity in brain regions overlapping with the DMN. METHODS: In 18 nicotine-dependent individuals, we assessed the relationship between DMN activation to smoking relative to neutral cues using functional magnetic resonance imaging and dACCGlu as measured by magnetic resonance spectroscopy. This association also was tested in a replication sample of 14 nicotine-dependent participants. RESULTS: Not only was the DMN significantly less suppressed during smoking cue exposure, but also there was a positive association between DMN reactivity to smoking relative to neutral cues and dACCGlu (r=0.56, p<0.02). This finding was confirmed in the independent replication cohort (r=0.64, p<0.02). CONCLUSIONS: The current findings confirm that the DMN is less suppressed when smokers view smoking relative to neutral cues, suggesting that smoking cues engage self-relevant processing. Furthermore, these results indicate that dACCGlu is associated with enhanced DMN engagement when nicotine-dependent individuals are exposed to self-relevant smoking cues.
Authors: Eric D Claus; Sara K Blaine; Francesca M Filbey; Andrew R Mayer; Kent E Hutchison Journal: Neuropsychopharmacology Date: 2013-05-24 Impact factor: 7.853
Authors: Matthew L LoPresti; Karin Schon; Marisa D Tricarico; Jascha D Swisher; Kim A Celone; Chantal E Stern Journal: J Neurosci Date: 2008-04-02 Impact factor: 6.167
Authors: R Nathan Spreng; W Dale Stevens; Jon P Chamberlain; Adrian W Gilmore; Daniel L Schacter Journal: Neuroimage Date: 2010-06-18 Impact factor: 6.556
Authors: Amy C Janes; Robert S Ross; Stacey Farmer; Blaise B Frederick; Lisa D Nickerson; Scott E Lukas; Chantal E Stern Journal: Addict Biol Date: 2013-11-22 Impact factor: 4.280
Authors: Wei Huang; Joseph R DiFranza; David N Kennedy; Nanyin Zhang; Douglas Ziedonis; Sanouri Ursprung; Jean A King Journal: PLoS One Date: 2013-07-04 Impact factor: 3.240
Authors: Kelly M Dumais; Teresa R Franklin; Kanchana Jagannathan; Nathan Hager; Michael Gawrysiak; Jennifer Betts; Stacey Farmer; Emily Guthier; Heather Pater; Amy C Janes; Reagan R Wetherill Journal: Drug Alcohol Depend Date: 2017-07-08 Impact factor: 4.492
Authors: Amy C Janes; Michael Datko; Alexandra Roy; Bruce Barton; Susan Druker; Carolyn Neal; Kyoko Ohashi; Hanif Benoit; Remko van Lutterveld; Judson A Brewer Journal: Neuropsychopharmacology Date: 2019-04-30 Impact factor: 7.853
Authors: Laura Murray; Julia C Welsh; Chase G Johnson; Roselinde H Kaiser; Todd J Farchione; Amy C Janes Journal: Drug Alcohol Depend Date: 2022-04-15 Impact factor: 4.852
Authors: Elena Molokotos; Alyssa L Peechatka; Kainan S Wang; Diego A Pizzagalli; Amy C Janes Journal: Drug Alcohol Depend Date: 2020-02-29 Impact factor: 4.492
Authors: Osama A Abulseoud; Thomas J Ross; Hyung Wook Nam; Elisabeth C Caparelli; Michael Tennekoon; Brooke Schleyer; Juan Castillo; John Fedota; Hong Gu; Yihong Yang; Elliot Stein Journal: Neuropsychopharmacology Date: 2020-06-19 Impact factor: 7.853
Authors: Heather Burrell Ward; Adam Beermann; Uzma Nawaz; Mark A Halko; Amy C Janes; Lauren V Moran; Roscoe O Brady Journal: Front Psychiatry Date: 2022-01-27 Impact factor: 5.435
Authors: Todd J Farchione; Hayley E Fitzgerald; Andrew Curreri; Amy C Janes; Matthew W Gallagher; Sophia Sbi; Elizabeth H Eustis; David H Barlow Journal: Contemp Clin Trials Date: 2021-07-17 Impact factor: 2.261